Which is stupid, because GLP-1 drugs cut down substantially on long term health problems. You’re not really saving the insurance industry any money by doing this.
this post was submitted on 31 Dec 2025
38 points (100.0% liked)
California
1981 readers
96 users here now
Welcome to /c/California, an online haven that brings to life the unrivaled diversity and vibrancy of California! This engaging community offers a virtual exploration of the Golden State, taking you from the stunning Pacific coastline to the rugged Sierra Nevada, and every town, city, and landmark in between. Discover California's world-class wineries, stunning national parks, innovative tech scene, robust agricultural heartland, and culturally diverse metropolises.
Discussions span a wide range of topics—from travel tips and restaurant recommendations to local politics and environmental issues. Whether you're a lifelong resident, a recent transplant, or planning your dream visit, /c/California is your one-stop place to share experiences, ask questions, and celebrate all the things that make California truly unique.
Related Communities:
Nearby Communities:
- California
- Bakersfield, CA
- Bay Area, CA
- Burbank, CA
- Fresno, CA
- Long Beach, CA
- Los Angeles, CA
- Oakland, CA
- San Diego, CA
- San Jose, CA
- San Francisco, CA
- Sacramento, CA
- Santa Clarita, CA
founded 2 years ago
MODERATORS
I'm against this cost saving measure proposed by Newsom's administration. Obesity is a health crisis in the US - It leads to many other health problems. The mentality of "we'll only give you GLP-1 drugs once you get diabetes" seems crazy to me. I wish our governments were able to price negotiate with the medicine's manufacturers instead of cutting it out of the healthcare system for Medi-Cal recipients.
I think American doctors should be allowed to prescribe GLP-1s for anyone obese. I don't want people with eating disorders to get it, so doctor supervision should still be practiced. But America has a huge obesity health crisis that needs to be discussed and addressed. GLP-1s are part of the solution, in my opinion.
It’s really a problem with our drug patent system. Private companies exploit public research money and alone reap the profits for blockbuster drugs. To the point where the country that paid for the majority of the research cannot afford to purchase said drug. This is how companies get larger valuations than the country they are headquartered in.